IRBESARTAN VIATRIS 300 mg, tablet 30 tablets, CIP 3400930151211
Active ingredients: Irbesartan
Commercialized according to BDPMDispensing in France: Prescription only
Tablet30 tablets, CIP 3400930151211orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IRBESARTAN VIATRIS 300 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 Jul 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68789755CIP73015121CIP133400930151211Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IRBÉSARTANcomprimé | 300 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.